SE9403055L - Nytt humant peptidantibiotikum (fall-39) och dess användning - Google Patents

Nytt humant peptidantibiotikum (fall-39) och dess användning

Info

Publication number
SE9403055L
SE9403055L SE9403055A SE9403055A SE9403055L SE 9403055 L SE9403055 L SE 9403055L SE 9403055 A SE9403055 A SE 9403055A SE 9403055 A SE9403055 A SE 9403055A SE 9403055 L SE9403055 L SE 9403055L
Authority
SE
Sweden
Prior art keywords
case
new human
human peptide
peptide antibiotic
polypeptides
Prior art date
Application number
SE9403055A
Other languages
English (en)
Swedish (sv)
Other versions
SE9403055D0 (sv
Inventor
Birgitta Agerberth
Hans G Boman
Gudmundur H Gudmundsson
Hans Gunne
Original Assignee
Hans G Boman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hans G Boman filed Critical Hans G Boman
Priority to SE9403055A priority Critical patent/SE9403055L/
Publication of SE9403055D0 publication Critical patent/SE9403055D0/xx
Priority to PCT/SE1995/001030 priority patent/WO1996008508A1/en
Priority to AU35368/95A priority patent/AU3536895A/en
Publication of SE9403055L publication Critical patent/SE9403055L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE9403055A 1994-09-13 1994-09-13 Nytt humant peptidantibiotikum (fall-39) och dess användning SE9403055L (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9403055A SE9403055L (sv) 1994-09-13 1994-09-13 Nytt humant peptidantibiotikum (fall-39) och dess användning
PCT/SE1995/001030 WO1996008508A1 (en) 1994-09-13 1995-09-12 A new human peptide antibiotic (fall-39) and its use
AU35368/95A AU3536895A (en) 1994-09-13 1995-09-12 A new human peptide antibiotic (fall-39) and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9403055A SE9403055L (sv) 1994-09-13 1994-09-13 Nytt humant peptidantibiotikum (fall-39) och dess användning

Publications (2)

Publication Number Publication Date
SE9403055D0 SE9403055D0 (sv) 1994-09-13
SE9403055L true SE9403055L (sv) 1996-03-14

Family

ID=20395220

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9403055A SE9403055L (sv) 1994-09-13 1994-09-13 Nytt humant peptidantibiotikum (fall-39) och dess användning

Country Status (3)

Country Link
AU (1) AU3536895A ( )
SE (1) SE9403055L ( )
WO (1) WO1996008508A1 ( )

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030022829A1 (en) * 2001-03-30 2003-01-30 Wendy Maury Novel antiviral activities primate theta defensins and mammalian cathelicidins
WO2002095076A2 (en) * 2001-05-23 2002-11-28 Kabushiki Kaisha Toyota Chuo Kenkyusho Modified polypeptides having protease-resistance and/or protease-sensitivity
AU2002351828A1 (en) * 2001-11-05 2003-05-19 Deutsches Krebsforschungszentrum Novel genetic markers for leukemias
SE0300207D0 (sv) 2003-01-29 2003-01-29 Karolinska Innovations Ab New use and composition
WO2004098536A2 (en) 2003-03-06 2004-11-18 The Regents Of The University Of California Anti-viral activity of cathelicidin peptides
US7173007B1 (en) * 2003-04-02 2007-02-06 The Regents Of The University Of California Therapy for microbial infections
US7776823B2 (en) 2003-10-21 2010-08-17 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
US7718618B2 (en) 2003-10-21 2010-05-18 The Regents Of The University Of California Human cathelicidin antimicrobial peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4674511A (en) * 1979-04-30 1987-06-23 American Hospital Supply Corporation Medical electrode
US5095916A (en) * 1985-06-20 1992-03-17 Medtronic, Inc. Cardioversion and defibrillation lead system
EP0416159B1 (de) * 1989-09-07 1995-05-24 Siemens Aktiengesellschaft Mehrteilige flächenhafte Elektrode für ein HF-Chirugie-gerät
US5063932A (en) * 1989-10-03 1991-11-12 Mieczyslaw Mirowski Controlled discharge defibrillation electrode

Also Published As

Publication number Publication date
WO1996008508A1 (en) 1996-03-21
SE9403055D0 (sv) 1994-09-13
AU3536895A (en) 1996-03-29

Similar Documents

Publication Publication Date Title
AU6819294A (en) Oral drug delivery compositions and methods
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
ATE125869T1 (de) Wachstumshormonfusionsproteine.
BR9507811B1 (pt) polipeptìdeos e composição farmacêutica.
ES2224637T3 (es) Formulaciones deproteina.
ATE458054T1 (de) Menschliches parathyroidhormon, modifikationen, herstellung und verwendung
AU5047090A (en) Tissue plasminogene activator derivative
WO1996024370B1 (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
SE9101838D0 (sv) Novel peptides and their use
SE9403055L (sv) Nytt humant peptidantibiotikum (fall-39) och dess användning
SE9604593D0 (sv) Antimicrobially active polypeptides
AU4363199A (en) Use of hmg proteins for the preparation of medicaments having cytotoxic activity
WO2002096467A3 (en) Pharmaceutical use for secreted bacterial effector proteins
KR927002373A (ko) 성장 호르몬 분비 활성을 갖는 폴리펩타이드 화합물
CA2071757A1 (en) Implant compositions containing a biologically active protein, peptide or polypeptide
DE60133654D1 (de) Arzneimittel enthaltend analgetische peptide
PH27446A (en) Compound with gastric acid inhibitory effect
ATE3416T1 (de) Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
SE9401480L (sv) En ny 78-resters polypeptid (NK-lysin) och dess användning
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
CA2154078A1 (en) Wound healing composition
EP1074264A4 (en) NEOVASCULARIZATION INHIBITORS
WO1989001490A3 (en) Biologically active molecules
CA2004764A1 (en) Ancrod proteins, their preparation and use
FI892254A7 (fi) a-aminoboronihappojohdannaisten käyttö peptidi- ja proteiinilääkeaineiden stabiloimiseen

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9403055-8